Comparing two treatments for enlarged prostate
Part of Cancer, Kidney & urinary clinical trials.
This trial compares Rezum and Urolift, two minimally invasive procedures that treat an enlarged prostate (BPH). It aims to see which one works better for men who have moderate to severe urinary symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and at least 50 years old
- You have an enlarged prostate (BPH) causing moderate to severe symptoms (IPSS score of 13 or higher)
- Your prostate volume is between 30 and 80 milliliters
- You have not had prostate surgery before
- You do not have a history of prostate cancer or current urinary infection
- You are not allergic to nickel, titanium, or polyester/polypropylene
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This trial compares two surgeries for men with an enlarged prostate who have trouble urinating and need a catheter. It helps find out which procedure works better for getting patients back to normal urination.
This study tests a new way to treat enlarged prostate symptoms using steam therapy. The treatment is planned with MRI scans and AI technology, which may make the procedure more precise and effective.
This trial compares two minimally invasive procedures for an enlarged prostate (benign prostatic hyperplasia). It tests whether water vapor thermal therapy or prostatic artery embolization works better to improve urinary symptoms.
This study compares two treatments for an enlarged prostate: Optilume (a catheter-based system) and Rezum (water vapor therapy). It's for men with moderate symptoms who haven't tried other treatments before.
This study compares two minimally invasive devices (iTind and UroLift) to treat urinary symptoms caused by an enlarged prostate. It is for men whose symptoms are bothersome enough to need treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.